Literature DB >> 1937490

Founder effect in familial hyperchylomicronemia among French Canadians of Quebec.

M De Braekeleer1, C Dionne, C Gagné, P Julien, D Brun, M R Ven Murthy, P J Lupien.   

Abstract

Familial hyperchylomicronemia has reached a high prevalence in the French Canadian population of eastern Quebec. The birth places of 58 carriers identified through the birth of one affected child clustered in three regions. The genealogies of these 58 individuals showed that no founder was common to all of them. Three sets of founders were found, one for each region, with little overlapping between two regions. These results strongly suggest that more than one mutation, introduced by the French migrants in the 17th century, are segregating in the French Canadian population. Perche, a region situated between Paris and Normandy, appeared to be the most likely putative center of diffusion of at least one mutation in the lipoprotein lipase gene segregating in the modern-day French Canadian population of Quebec.

Entities:  

Mesh:

Year:  1991        PMID: 1937490     DOI: 10.1159/000153996

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  9 in total

1.  Predominance of the T14484C mutation in French-Canadian families with Leber hereditary optic neuropathy is due to a founder effect.

Authors:  C Macmillan; T A Johns; K Fu; E A Shoubridge
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  The French Canadian Tay-Sachs disease deletion mutation: identification of probable founders.

Authors:  M De Braekeleer; P Hechtman; E Andermann; F Kaplan
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

3.  Time and space clusters of the French-Canadian M1V phenylketonuria mutation in France.

Authors:  S Lyonnet; D Melle; M de Braekeleer; R Laframboise; F Rey; S W John; M Berthelon; J Berthelot; H Journel; B Le Marec
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

4.  Support for founder effect for two lipoprotein lipase (LPL) gene mutations in French Canadians by analysis of GT microsatellites flanking the LPL gene.

Authors:  S Wood; M Schertzer; M Hayden; Y Ma
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

5.  Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean.

Authors:  C Morin; G Mitchell; J Larochelle; M Lambert; H Ogier; B H Robinson; M De Braekeleer
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

6.  Genetic epidemiology of sensorimotor polyneuropathy with or without agenesis of the corpus callosum in northeastern Quebec.

Authors:  M De Braekeleer; A Dallaire; J Mathieu
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

7.  Mutation profiles of phenylketonuria in Quebec populations: evidence of stratification and novel mutations.

Authors:  R Rozen; A Mascisch; M Lambert; R Laframboise; C R Scriver
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

8.  Geographic distribution and genealogy of mutation 207 of the lipoprotein lipase gene in the French Canadian population of Québec.

Authors:  T Normand; J Bergeron; T Fernandez-Margallo; A Bharucha; M R Ven Murthy; P Julien; C Gagné; C Dionne; M De Braekeleer; R Ma
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

9.  The burden of familial chylomicronemia syndrome in Canadian patients.

Authors:  Daniel Gaudet; Michael Stevenson; Nelly Komari; Grace Trentin; Caroline Crowson; Nandini Hadker; Sophie Bernard
Journal:  Lipids Health Dis       Date:  2020-06-02       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.